STAT3 activation abrogates growth factor dependence and contributes to head and neck squamous cell carcinoma tumor

Taro Kijima1, Hideo Niwa, Richard A Steinman

  • 1Departments of Otolaryngology, University of Pittsburgh School of Medicine and University of Pittsburgh Cancer Institute, Pittsburgh, Pennsylvania 15213, USA.

Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research
|August 24, 2002
PubMed

Insights

Constitutive activation of Signal Transducers and Activators of Transcription 3 (STAT3) drives tumor growth in head and neck squamous cell carcinoma (HNSCC). This STAT3 activation promotes cancer progression independently of Epidermal Growth Factor Receptor (EGFR) signaling.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Epidermal growth factor receptor (EGFR) is often upregulated in head and neck squamous cell carcinoma (HNSCC), contributing to uncontrolled cell growth.
  • Previous research linked autocrine EGFR stimulation to constitutive Signal Transducers and Activators of Transcription 3 (STAT3) activation in HNSCC.

Purpose of the Study:

  • To investigate the role of activated STAT3 in HNSCC tumor progression.
  • To determine if STAT3 activation contributes to mitogenic signaling independently of EGFR.

Main Methods:

  • Stable transfection of HNSCC cells with a dominant-active STAT3 construct.
  • Analysis of STAT3 target gene expression (Bcl-X(L), cyclin D1).
  • In vitro proliferation assays and in vivo tumor growth rate assessments.
  • Cell cycle analysis.

Main Results:

  • HNSCC cells with activated STAT3 showed increased expression of target genes like Bcl-X(L) and cyclin D1.
  • These cells exhibited enhanced proliferation in vitro and accelerated tumor growth in vivo.
  • Cell cycle analysis revealed a higher proportion of cells in the G(2)-M phase.

Conclusions:

  • Constitutive STAT3 activation promotes tumor growth in HNSCC.
  • STAT3 contributes to HNSCC progression independently of the EGFR autocrine pathway.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Loss of Tumor Suppressor Gene Functions01:12

Loss of Tumor Suppressor Gene Functions

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...